Danilov AV, Flinn IW, Davids MS, Gregory B, et al. The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival. Haematologica 2024 May 30. doi: 10.3324/haematol.2024.285043.
PMID: 38813715